Literature DB >> 11880443

Comparative performance of herpes simplex virus type 1-specific serologic assays from MRL and Meridian Diagnostics.

Julie A Ribes1, Angela Smith, Marie Hayes, Doris J Baker, Jeffrey L Winters.   

Abstract

Two companies, MRL and Meridian Diagnostics, have developed Food and Drug Administration-approved herpes simplex virus type 1 type-specific enzyme immunoassays. The sensitivity, specificity, and overall testing efficiency of these assays were 98.2, 93.8, and 96.6% for MRL and 98.8, 99.0, and 98.1% for Meridian, making both of these kits suitable for use in the clinical lab.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11880443      PMCID： PMC120264          DOI： 10.1128/JCM.40.3.1071-1072.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  13 in total

Review 1.  Genital herpes infection: a review.

Authors:  R Brugha; K Keersmaekers; A Renton; A Meheus
Journal:  Int J Epidemiol       Date:  1997-08       Impact factor: 7.196

2.  A clinical study for the control of facial mucocutaneous herpes virus infections. I. Characterization of natural history in a professional school population.

Authors:  S K Young; N H Rowe; R A Buchanan
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1976-04

3.  Acute respiratory disease of university students with special reference to the etiologic role of Herpesvirus hominis.

Authors:  W P Glezen; G W Fernald; J A Lohr
Journal:  Am J Epidemiol       Date:  1975-02       Impact factor: 4.897

4.  A cross-sectional study of herpes simplex virus types 1 and 2 in college students: occurrence and determinants of infection.

Authors:  J J Gibson; C A Hornung; G R Alexander; F K Lee; W A Potts; A J Nahmias
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

5.  The natural history of recurrent facial-oral infection with herpes simplex virus.

Authors:  C Bader; C S Crumpacker; L E Schnipper; B Ransil; J E Clark; K Arndt; I M Freedberg
Journal:  J Infect Dis       Date:  1978-12       Impact factor: 5.226

6.  Clinical and virological studies on genital herpes.

Authors:  T Kawana; T Kawaguchi; S Sakamoto
Journal:  Lancet       Date:  1976-10-30       Impact factor: 79.321

7.  Six-year study of the incidence of herpes in genital and nongenital cultures in a central Kentucky medical center patient population.

Authors:  J A Ribes; A D Steele; J P Seabolt; D J Baker
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

8.  Comparative performance of herpes simplex virus type 2-specific serologic assays from Meridian Diagnostics and MRL diagnostics.

Authors:  J A Ribes; M Hayes; A Smith; J L Winters; D J Baker
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

Review 9.  Genital herpes simplex virus infections: clinical manifestations, course, and complications.

Authors:  L Corey; H G Adams; Z A Brown; K K Holmes
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

10.  Epidemiology of genital herpes infections in Sweden.

Authors:  G B Löwhagen; E Jansen; E Nordenfelt; E Lycke
Journal:  Acta Derm Venereol       Date:  1990       Impact factor: 4.437
View more
  8 in total

1.  Longitudinal reliability of focus glycoprotein G-based type-specific enzyme immunoassays for detection of herpes simplex virus types 1 and 2 in women.

Authors:  Thomas L Cherpes; Rhoda L Ashley; Leslie A Meyn; Sharon L Hillier
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

2.  Comparative performance of a novel herpes simplex virus type 2-specific enzyme-linked immunosorbent assay using a targeted chain oligopeptide, peptide 55.

Authors:  A M Al-Sulaiman; P J Vallely; P E Klapper
Journal:  Clin Vaccine Immunol       Date:  2009-04-15

3.  Adolescent Sexually Transmitted Diseases: Recent Developments.

Authors:  Diane R. Blake
Journal:  Curr Infect Dis Rep       Date:  2004-04       Impact factor: 3.725

Review 4.  Light microscopy, culture, molecular, and serologic methods for detection of herpes simplex virus.

Authors:  Neil W Anderson; Blake W Buchan; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2013-10-16       Impact factor: 5.948

5.  Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012.

Authors:  Katharine J Looker; Amalia S Magaret; Margaret T May; Katherine M E Turner; Peter Vickerman; Sami L Gottlieb; Lori M Newman
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

6.  The association between herpes virus infections and functional somatic symptoms in a general population of adolescents. The TRAILS study.

Authors:  Iris Jonker; Robert Schoevers; Hans Klein; Judith Rosmalen
Journal:  PLoS One       Date:  2017-10-18       Impact factor: 3.240

7.  Childhood life events, immune activation and the development of mood and anxiety disorders: the TRAILS study.

Authors:  I Jonker; J G M Rosmalen; R A Schoevers
Journal:  Transl Psychiatry       Date:  2017-05-02       Impact factor: 6.222

8.  Seroepidemiology of Herpes Simplex virus type 1 and 2 in Western and Southern Switzerland in adults aged 25-74 in 1992-93: a population-based study.

Authors:  Dominique Bünzli; Vincent Wietlisbach; Fabrizio Barazzoni; Roland Sahli; Pascal R A Meylan
Journal:  BMC Infect Dis       Date:  2004-03-17       Impact factor: 3.090
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.